Candidate drug replacements for quinacrine in cutaneous lupus erythematosus

被引：7
作者：
Yan, Daisy [1 ,2 ]
Borucki, Robert [1 ,2 ]
Sontheimer, Richard D. [3 ]
Werth, Victoria P. [1 ,2 ]
机构：
[1] Corporal Michael J Crescenz VA Med Ctr, Dept Dermatol, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Dermatol, Perelman Sch Med, Philadelphia, PA 19104 USA
[3] Univ Utah, Sch Med, Dept Dermatol, Salt Lake City, UT USA
来源：
LUPUS SCIENCE & MEDICINE | 2020年 / 7卷 / 01期
基金：
美国国家卫生研究院;
关键词：
autoimmune diseases; lupus erythematosus; systemic; methotrexate; PIMECROLIMUS 1-PERCENT CREAM; DISCOID SKIN-LESIONS; DOUBLE-BLIND; POLYPODIUM-LEUCOTOMOS; INTRAVENOUS IMMUNOGLOBULIN; MYCOPHENOLATE-MOFETIL; ANTIMALARIAL AGENTS; EFFICACY; HYDROXYCHLOROQUINE; METHOTREXATE;
D O I：
10.1136/lupus-2020-000430
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Cutaneous lupus erythematosus (CLE) is a disfiguring and potentially disabling disease that causes significant morbidity in patients. Antimalarials are an important class of medication used to treat this disease and have been the first-line systemic therapy since the 1950s. Quinacrine, in particular, is used as an adjuvant therapy to other antimalarials for improved control of CLE. Quinacrine is currently unavailable in the USA, which has taken away an important component of the treatment regimen of patients with CLE. This paper reviews the evidence of available local and systemic therapies in order to assist providers in choosing alternative treatments for patients who previously benefited from quinacrine therapy.
引用
收藏
页数：8
相关论文
共 96 条
  • [11] The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score
    Braunstein, I.
    Klein, R.
    Okawa, J.
    Werth, V. P.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2012, 166 (05) : 971 - 975
  • [12] Breithaupt AD, 2012, CUTIS, V89, P183
  • [13] Caccialanza M, 2011, GIORN ITAL DERMAT V, V146, P85
  • [14] AZATHIOPRINE - AN EFFECTIVE, CORTICOSTEROID-SPARING THERAPY FOR PATIENTS WITH RECALCITRANT CUTANEOUS LUPUS-ERYTHEMATOSUS OR WITH RECALCITRANT CUTANEOUS LEUKOCYTOCLASTIC VASCULITIS
    CALLEN, JP
    SPENCER, LV
    BURRUSS, JB
    HOLTMAN, J
    [J]. ARCHIVES OF DERMATOLOGY, 1991, 127 (04) : 515 - 522
  • [15] TLR7/TLR8 Activation Restores Defective Cytokine Secretion by Myeloid Dendritic Cells but Not by Plasmacytoid Dendritic Cells in HIV-Infected Pregnant Women and Newborns
    Cardoso, Elaine Cristina
    Pereira, Natalli Zanete
    Mitsunari, Gabrielle Eimi
    da Silva Oliveira, Luanda Mara
    Ruocco, Rosa Maria S. A.
    Vieira Francisco, Rossana Pulcineli
    Zugaib, Marcelo
    da Silva Duarte, Alberto Jose
    Sato, Maria Notomi
    [J]. PLOS ONE, 2013, 8 (06):
  • [16] Risk of thromboembolic events in patients treated with thalidomide for cutaneous lupus erythematosus: A multicenter retrospective study
    Cesbron, Elise
    Bessis, Didier
    Jachiet, Marie
    Lipsker, Dan
    Cordel, Nadege
    Bouaziz, Jean-David
    Bagot, Martine
    Arnaud, Laurent
    Barbaud, Annick
    Frances, Camille
    Chasset, Francois
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (01) : 162 - 165
  • [17] Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis
    Chan, TM
    Li, FK
    Tang, CSO
    Wong, RWS
    Fang, GX
    Ji, YL
    Lau, CS
    Wong, AKM
    Tong, MKL
    Chan, KW
    Lai, KN
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (16) : 1156 - 1162
  • [18] Response to Antimalarial Agents in Cutaneous Lupus Erythematosus
    Chang, Aileen Y.
    Piette, Evan W.
    Foering, Kristen P.
    Tenhave, Thomas R.
    Okawa, Joyce
    Werth, Victoria P.
    [J]. ARCHIVES OF DERMATOLOGY, 2011, 147 (11) : 1261 - 1267
  • [19] Efficacy and tolerance profile of thalidomide in cutaneous lupus erythematosus: A systematic review and meta-analysis
    Chasset, Francois
    Tounsi, Toufik
    Cesbron, Elise
    Barbaud, Annick
    Frances, Camille
    Arnaud, Laurent
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (02) : 342 - +
  • [20] Changing antimalarial agents after inefficacy or intolerance in patients with cutaneous lupus erythematosus: A multicenter observational study
    Chasset, Francois
    Arnaud, Laurent
    Jachiet, Marie
    Monfort, Jean-Benoit
    Bouaziz, Jean-David
    Cordoliani, Florence
    Bagot, Martine
    Barbaud, Annick
    Frances, Camille
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (01) : 107 - +
12345678910